Bierbower Elizabeth D 4

4 · Progyny, Inc. · Filed May 26, 2026

AI-generated summary of this filing

Updated May 26, 2026

Progyny (PGNY) Director Elizabeth Bierbower Receives Stock Awards

What Happened

Director Elizabeth D. Bierbower received equity awards from Progyny on May 21, 2026. The filing shows three grants: 5,660 RSUs (no purchase price), 3,203 derivative shares at $12.49 valued at $40,005, and 27,119 derivative shares (no purchase price). Total shares/rights granted equal 35,982; only the 3,203-share grant shows a reported dollar value ($40,005).

Key Details

Transaction date: May 21, 2026; Form 4 filed May 26, 2026 (five days after the transaction; Form 4s are generally due within two business days).
Grants and reported amounts: 5,660 RSUs @ $0; 3,203 derivative shares @ $12.49 (reported value $40,005); 27,119 derivative shares @ $0.
Shares owned after transaction: not specified in the provided filing excerpt.
Footnotes: F1 = RSUs (each RSU converts to one common share on vesting). F2 = the 3,203-share option was issued in lieu of an annual cash retainer (~$39,990). F3 = additional shares/option awards subject to the same vesting condition below.
Vesting: awards vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the issuer’s first annual meeting following the grant date, subject to the director’s continued service.

Context

These were grants/awards (not open-market purchases or sales). RSUs and option-like derivative awards do not represent immediate purchases — they are contingent rights that typically vest over time and convert to shares on vesting.
The 3,203-share derivative was issued in lieu of cash compensation (board retainer), which is a common non-cash director compensation practice and not a market-direction signal. The filing timing (filed five days after the grant) appears later than the usual two-business-day Form 4 deadline.

Form 4

Period: 2026-05-21

Director

Transactions

Award
Common Stock
[F1]
2026-05-21+5,660→ 5,660 total
Award
Stock Option (Right to Buy)
[F2]
2026-05-21$12.49/sh+3,203$40,005→ 3,203 total
Exercise: $24.69Exp: 2036-05-20→ Common Stock (3,203 underlying)
Award
Stock Option (Right to Buy)
[F3]
2026-05-21+27,119→ 27,119 total
Exercise: $24.69Exp: 2036-05-20→ Common Stock (27,119 underlying)

Footnotes (3)

[F1]Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
[F2]The option was issued to the Reporting Person in lieu of an annual cash retainer of $39,990 for board and committee service. The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.
[F3]The shares subject to the option will vest on the earlier of (i) May 21, 2027 or (ii) the calendar day immediately preceding the date of the Issuer's first annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on such date.

Signature

/s/ Mark Livingston, Attorney-in-Fact|2026-05-26

1 file